Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus

被引:65
作者
Spiller, OB
Blackbourn, DJ
Mark, L
Proctor, DG
Blom, AM [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Dept Clin Chem, S-20502 Malmo, Sweden
[2] Univ Glasgow, Inst Biomed & Life Sci, Div Virol, Glasgow G11 5JR, Lanark, Scotland
[3] Cardiff Univ, Coll Med, Virus Receptor & Immune Evas Grp, Dept Med Biochem, Cardiff CF14 4XX, S Glam, Wales
关键词
D O I
10.1074/jbc.M211579200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV) is closely associated with Kaposi's sarcoma and certain B-cell lymphomas. The fourth open reading frame of the KSHV genome encodes a protein (KSHV complement control protein (KCP, previously termed ORF4)) predicted to have complement-regulating activity. Here, we show that soluble KCP strongly enhanced the decay of classical C3-convertase but not the alternative pathway C3-convertase, when compared with the host complement regulators: factor H, C4b-binding protein, and decay-accelerating factor. The equilibrium affinity constant (K-D) of KCP for C3b and C4b was determined by surface plasmon resonance analysis to range between 0.47-10 muM and 0.025-6.1 muM, respectively, depending on NaCl concentration and cation presence. Soluble and cell-associated KCP acted as a cofactor for factor I (FI)-mediated cleavage of both C4b and C3b and induced the cleavage products C4d and iC3b, respectively. In the presence of KCP, FI further cleaved iC3b to C3d, which has never been described before as complement receptor 1 only mediates the production of C3dg by FI. KCP would enhance virus pathogenesis through evading complement attack, opsonization, and anaphylaxis but may also aid in targeting KSHV to one of its host reservoirs since C3d is a ligand for complement receptor 2 on B-cells.
引用
收藏
页码:9283 / 9289
页数:7
相关论文
共 39 条
  • [1] NEW MEMBER OF THE MULTIGENE FAMILY OF COMPLEMENT CONTROL PROTEINS IN HERPESVIRUS SAIMIRI
    ALBRECHT, JC
    FLECKENSTEIN, B
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (06) : 3937 - 3940
  • [2] HERPES-LIKE SEQUENCES IN HIV-INFECTED AND UNINFECTED KAPOSIS-SARCOMA PATIENTS
    AMBROZIAK, JA
    BLACKBOURN, DJ
    HERNDIER, BG
    GLOGAU, RG
    GULLETT, JH
    MCDONALD, AR
    LENNETTE, ET
    LEVY, JA
    [J]. SCIENCE, 1995, 268 (5210) : 582 - 583
  • [3] INHIBITION OF COMPLEMENT COMPONENTS C3 AND C4 BY CADRALAZINE AND ITS ACTIVE METABOLITE
    ANDERSSON, M
    HANSON, A
    ENGLUND, G
    DAHLBACK, B
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) : 261 - 265
  • [4] Kaposi's sarcoma
    Antman, K
    Chang, Y
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) : 1027 - 1038
  • [5] CCP1-4 of the C4b-binding protein α-chain are required for factor I mediated cleavage of complement factor C3b
    Blom, AM
    Kask, L
    Dahlbäck, B
    [J]. MOLECULAR IMMUNOLOGY, 2003, 39 (10) : 547 - 556
  • [6] The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases
    Cesarman, E
    Knowles, DM
    [J]. SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) : 165 - 174
  • [7] IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA
    CHANG, Y
    CESARMAN, E
    PESSIN, MS
    LEE, F
    CULPEPPER, J
    KNOWLES, DM
    MOORE, PS
    [J]. SCIENCE, 1994, 266 (5192) : 1865 - 1869
  • [8] PURIFICATION OF THE HUMAN-COMPLEMENT CONTROL PROTEIN C3B INACTIVATOR
    CROSSLEY, LG
    PORTER, RR
    [J]. BIOCHEMICAL JOURNAL, 1980, 191 (01) : 173 - 182
  • [9] DEGRADATION OF HUMAN-COMPLEMENT COMPONENT-C4B IN THE PRESENCE OF THE C4B-BINDING PROTEIN PROTEIN-S COMPLEX
    DAHLBACK, B
    HILDEBRAND, B
    [J]. BIOCHEMICAL JOURNAL, 1983, 209 (03) : 857 - 863
  • [10] PURIFICATION OF HUMAN C4B-BINDING PROTEIN AND FORMATION OF ITS COMPLEX WITH VITAMIN-K-DEPENDENT PROTEIN-S
    DAHLBACK, B
    [J]. BIOCHEMICAL JOURNAL, 1983, 209 (03) : 847 - 856